|
Hong, Seung-Chul; Lin, Ling; Lo, Betty et al. (2007) DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans. Hum Immunol 68:59-68
|
|
Mignot, Emmanuel; Nishino, Seiji (2005) Emerging therapies in narcolepsy-cataplexy. Sleep 28:754-63
|
|
Nishino, S; Kanbayashi, T; Fujiki, N et al. (2003) CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies. Neurology 61:823-5
|
|
Salomon, Ronald M; Ripley, Beth; Kennedy, John S et al. (2003) Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry 54:96-104
|
|
Vankova, Jitka; Stepanova, Iva; Jech, Robert et al. (2003) Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C. Sleep 26:427-30
|
|
Mignot, Emmanuel; Lammers, Gert Jan; Ripley, Beth et al. (2002) The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59:1553-62
|
|
Hong, Seung-Chul; Leen-Kim; Park, Soo-A et al. (2002) HLA and hypocretin studies in Korean patients with narcolepsy. Sleep 25:440-4
|
|
Okun, Michele L; Lin, Ling; Pelin, Zerrin et al. (2002) Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep 25:27-35
|
|
Hungs, M; Lin, L; Okun, M et al. (2001) Polymorphisms in the vicinity of the hypocretin/orexin are not associated with human narcolepsy. Neurology 57:1893-5
|
|
Nishino, S; Ripley, B; Overeem, S et al. (2001) Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 50:381-8
|
Showing the most recent 10 out of 36 publications
